122 related articles for article (PubMed ID: 1286221)
1. Higher cortical dysfunction, antiphospholipid antibodies and neuroradiological examinations in systemic lupus erythematosus.
Maeshima E; Yamada Y; Yukawa S; Nomoto H
Intern Med; 1992 Oct; 31(10):1169-74. PubMed ID: 1286221
[TBL] [Abstract][Full Text] [Related]
2. [Antiphospholipid antibodies and regional cerebral blood flow in systemic lupus erythematosus].
Maeshima E; Maeshima S; Yamada Y; Yukawa S
Ryumachi; 1993 Apr; 33(2):125-30. PubMed ID: 8316902
[TBL] [Abstract][Full Text] [Related]
3. Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus.
Postiglione A; De Chiara S; Soricelli A; Oriente A; Ruocco A; Spadaro G; Montefusco S; Marone G; Genovese A
Int J Clin Lab Res; 1998; 28(1):34-8. PubMed ID: 9594361
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies--our experience.
Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
[TBL] [Abstract][Full Text] [Related]
5. Lupus anticoagulants and antiphospholipid antibodies monitoring in systemic lupus erythematosus.
Ariano CC; Salmaggi A; Croci D; Lamperti E; Bottero P; Castiglione A; Venegoni E; La Mantia L; Eoli M
Contrib Nephrol; 1992; 99():118-22. PubMed ID: 1458916
[No Abstract] [Full Text] [Related]
6. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.
Perez-Villa F; Font J; Azqueta M; Espinosa G; Pare C; Cervera R; Reverter JC; Ingelmo M; Sanz G
Arthritis Rheum; 2005 Jun; 53(3):460-7. PubMed ID: 15934103
[TBL] [Abstract][Full Text] [Related]
7. Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus.
Donders RC; Kappelle LJ; Derksen RH; Algra A; Horbach DA; de Groot PG; van Gijn J
Neurology; 1998 Aug; 51(2):535-40. PubMed ID: 9710031
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
9. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
11. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
Plazak W; Gryga K; Milewski M; Podolec M; Kostkiewicz M; Podolec P; Musial J
Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
[TBL] [Abstract][Full Text] [Related]
12. Significance of antiphospholipid antibodies in lupus nephritis.
Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
[TBL] [Abstract][Full Text] [Related]
13. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus.
Falcao CA; Alves IC; Chahade WH; Duarte AL; Lucena-Silva N
Arq Bras Cardiol; 2002 Sep; 79(3):285-91. PubMed ID: 12386730
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies in patients with childhood onset systemic lupus erythematosus and their relatives. A French cooperative study.
Levy M; Molta C; Meyer O; Dosquet C; Danon F; Babron MC; Montes de Oca M
Contrib Nephrol; 1992; 99():26-34. PubMed ID: 1458923
[No Abstract] [Full Text] [Related]
15. Serum apolipoprotein H levels in systemic lupus erythematosus are not influenced by antiphospholipid antibodies.
Ichikawa Y; Takamatsu K; Shimizu H; Uchiyama M; Moriuchi J; Takaya M; Kobayashi N; Kawada T; Arimori S
Lupus; 1992 May; 1(3):145-9. PubMed ID: 1301975
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of antiphospholipid antibodies.
Petri M
Rheum Dis Clin North Am; 1994 May; 20(2):443-69. PubMed ID: 8016420
[TBL] [Abstract][Full Text] [Related]
18. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic findings in asymptomatic systemic lupus erythematosus patients.
Mohammed AG; Alghamdi AA; ALjahlan MA; Al-Homood IA
Clin Rheumatol; 2017 Mar; 36(3):563-568. PubMed ID: 27866289
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
